InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Weinberg Jonathan, Directeur Juridique. Insider active across 1 company, notably Evolent Health, Inc.. In total, 17 disclosures have been logged. History available since 4 May 2021. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Weinberg Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
2,650 股@ US$5.740.0024% mcap1.5% 占其流量Class A Common StockSEC:0001642833-26-000004:1
43,055 股0Class A Common StockSEC:0001642833-26-000004:0
4,406 股@ US$3.251.6% 占其流量Class A Common StockSEC:0001642833-26-000002:0
23,394 股0Class A Common StockSEC:0001628908-25-000105:0
8,808 股@ US$8.998.9% 占其流量Class A Common StockSEC:0001628908-25-000026:0
25,253 股@ US$13.9537.2% 占其流量Class A Common StockSEC:0001628908-24-000098:0
21,822 股0Class A Common StockSEC:0001628908-24-000036:0
11,550 股0Class A Common StockSEC:0001628908-24-000019:0
12,758 股0Class A Common StockSEC:0001628908-23-000037:0
11,550 股0Class A Common StockSEC:0001628908-23-000025:0
14,335 股@ US$10.2716.8% 占其流量Class A Common StockSEC:0001628908-22-000113:0
53,789 股0Class A Common StockSEC:0001628908-22-000041:0
20,000 股0Class A Common StockSEC:0001628908-22-000031:0
28,000 股@ US$3.8412.3% 占其流量Class A Common StockSEC:0001628908-21-000128:0
8,254 股@ US$3.843.6% 占其流量Class A Common StockSEC:0001628908-21-000120:0
1,900 股@ US$3.840.8% 占其流量Class A Common StockSEC:0001628908-21-000118:0
20,000 股@ US$3.848.5% 占其流量Class A Common StockSEC:0001628908-21-000056:0
17 条申报中的 17 条
About Weinberg Jonathan
Jonathan Weinberg is the General Counsel at Evolent Health, Inc., a company specializing in healthcare solutions. In his role, Jonathan is responsible for the company's legal affairs, including compliance and risk management. His expertise in business law is essential to support Evolent's operations.
